STOCK TITAN

Presurance Holdings, Inc. 8-K Filings

PRHI NASDAQ

Every 8-K that Presurance Holdings, Inc. (PRHI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow PRHI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRHI filings page.

Rhea-AI Summary

Presurance Holdings, Inc. reported stronger profitability for the quarter and six months ended June 30, 2026, while materially shrinking premium volume as it reshapes its book. First-half net income doubled to $5.2 million ($1.66 per share) from $2.6 million ($1.47 per share). The first-half combined ratio improved to 86.4% from 131.2%, reflecting better underwriting performance and favorable prior-year reserve development.

For the second quarter, net income was $2.5 million on net earned premiums of $6.8 million, with a combined ratio of 69.5%, including 31 percentage points of favorable prior-year development. Gross written premiums declined 38.0% in the quarter and 34.1% year-to-date as the company exited legacy commercial lines; personal lines comprised 100% of gross written premium in the quarter, driven largely by Texas homeowners. Adjusted operating income turned positive to $1.3 million in the quarter from a loss of $2.1 million a year earlier. Book value stood at $7.41 per share, and total shareholders’ equity was $27.7 million as of June 30, 2026.

Rhea-AI Summary

Presurance Holdings, Inc. reported results from its June 3, 2026 virtual annual shareholder meeting. Shareholders elected Class II directors Timothy M. Lamothe and Isolde G. O'Hanlon to three-year terms ending at the 2029 annual meeting and ratified Grant Thornton LLP as independent auditor for 2026.

As of the April 20, 2026 record date, 26,222,881 common shares were outstanding and entitled to vote. A quorum was reached, with 21,552,879 shares represented (approximately 82.2% of outstanding shares). Each director received about 19 million votes in favor, and the auditor ratification received over 20.5 million votes for.

Rhea-AI Summary

Presurance Holdings, Inc. is implementing a 1-for-7 reverse stock split of its common stock to help maintain compliance with Nasdaq listing requirements. The split becomes effective at 5:00 p.m. Eastern Time on June 1, 2026, with trading on a split-adjusted basis starting June 2, 2026.

Every 7 issued and outstanding shares of common stock will be combined into 1 share, with no change to the par value or the 100 million authorized shares. The number of outstanding shares will decrease from approximately 26.2 million to approximately 3.7 million, and fractional shares will be rounded down with cash paid for the fraction based on the closing Nasdaq price before effectiveness.

Rhea-AI Summary

Presurance Holdings reported much stronger results for the first quarter of 2026 as it continues to refocus on personal lines. Net income rose to $2.6 million, or $0.15 per share, from $522,000, or $0.04 per share, helped by better underwriting and favorable fair value adjustments.

Gross written premiums fell 29.1% to $11.5 million as the company exited commercial lines, but underwriting quality improved. The overall combined ratio improved to 105.7% from 140.5%, while personal lines achieved a profitable combined ratio of 97.9%. Despite the GAAP profit, Presurance still posted an adjusted operating loss of $2.8 million, or $(0.16) per share, highlighting that core operations are not yet consistently profitable.

Rhea-AI Summary

Presurance Holdings reported a weak fourth quarter of 2025 as it continues to exit legacy commercial lines. The company posted a net loss allocable to common shareholders of $17.0 million, or $(1.39) per diluted share, on total revenue and other income of $4.6 million. Gross written premiums for the quarter fell to $7.9 million from $13.7 million, reflecting the runoff of underperforming commercial business.

Results for the full year were also negative. Net loss allocable to common shareholders was $18.4 million, or $(1.51) per share, and adjusted operating loss was $25.6 million, or $(2.10) per share. The consolidated combined ratio reached 333.5% in the quarter and 168.8% for the year, indicating heavy underwriting losses. Book value per common share declined to $0.73 from $1.76 as of year-end, while personal lines gross written premiums grew 12.7% in 2025 to $51.1 million and represented 100% of fourth-quarter gross written premium.

Rhea-AI Summary

Presurance Holdings, Inc. has been notified by Nasdaq that its common stock no longer meets the minimum bid price requirement because the closing bid has stayed below $1.00 per share for 30 consecutive business days. The company has until August 31, 2026 to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days.

If it fails to do so, Presurance may qualify for an additional 180 days if it meets other Nasdaq listing standards and formally commits to curing the deficiency. Shareholders previously approved a reverse stock split in June 2025 at a ratio between 1-for-2 and 1-for-12, and the board can choose the exact ratio any time before June 3, 2026, but plans to use this tool only if it believes it is in shareholders’ best interests. If compliance is not restored, Nasdaq could move to delist the common stock, which the company would be able to appeal.

Rhea-AI Summary

Presurance Holdings, Inc. completed a rights offering and related financing that raised an aggregate of $14,000,000 in gross proceeds from subscribers and backstop purchasers. Investors exercised rights to buy 4,284,640 common shares at $1.00 per share, and backstop purchasers acquired 9,715,360 additional shares.

The company used a substantial portion of the proceeds to repurchase and redeem all outstanding Series B Preferred Stock from an affiliate of a board member for an aggregate redemption price of $7.5 million, including accrued dividends, and to pay all accrued preferred dividends. Remaining funds are earmarked for general corporate purposes. Presurance also filed a Certificate of Correction to the Series B designation and amended an existing warrant to correct errors and limit holder rights.